Quality Antibodies, Quality Results
GeneTex, Inc. was founded by three internationally renowned scientists with recognized expertise in clinical oncology, cancer biology and infectious diseases. Based on their breadth of experience and research interests, the company's initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists studying the underlying mechanisms common to many forms of cancer. GeneTex’s product portfolio has expanded to cover research areas including cancer, cell biology, epigenetics, immunology, infectious disease, metabolism, neuroscience, signal transduction, stem cell development and zebrafish biology.
- Over 46.000 Primary Antibodies for different species and applications
- Secondary Antibodies
- Proteins and Peptides
- Cell Lysates and Serum